Is Long-acting Cabotegravir a Pre-exposure Prophylaxis Option for Women of Childbearing Potential?

Eric G Sahloff, Nikki Hamons, Kevin Baumgartner,Joan M Duggan

OPEN FORUM INFECTIOUS DISEASES（2022）

引用 2|浏览0

暂无评分

摘要

Long-acting cabotegravir (CAB-LA) provides an exciting new option for pre-exposure prophylaxis (PrEP) in multiple populations. In this Perspective, we consider the unique pharmacokinetics of CAB-LA and the potential impact on the prescribing of CAB-LA, specifically in cis-women of reproductive potential.

查看译文

关键词

cabotegravir, HIV, pre-exposure prophylaxis, women

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要